Procytox 25 mg – DIN 02241795
Procytox is Cyclophosphamide 25 mg (tablet), sold in Canada. It is used for multiple sclerosis, myasthenia gravis and breast cancer. It is supplied by Baxter Corporation. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Cyclophosphamide 25 mg
- Brand
- Procytox
- Strength
- 25 mg
- Used for
- Multiple sclerosis, myasthenia gravis and breast cancer
- Form
- Tablet
- Manufacturer
- Baxter Corporation
- Drug class
- Cancer or immune medicine
- Sold in
- Canada
- DIN
- 02241795
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Cyclophosphamide used for?
Cyclophosphamide is used for multiple sclerosis, myasthenia gravis, breast cancer and multiple myeloma.
- Medicine type
- Cancer or immune medicine
Official uses from the US prescribing label
Malignant Diseases
Cyclophosphamide capsules are indicated for the treatment of: • malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin’s disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma • multiple myeloma • leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia (cyclophosphamide given during remission is effective in prolonging its duration) • mycosis fungoides (advanced disease) • neuroblastoma (disseminated disease) • adenocarcinoma of the ovary • retinoblastoma • carcinoma of the breast
Cyclophosphamide capsules, although effective alone in susceptible malignancies, is more frequently used concurrently or sequentially with other antineoplastic drugs.
Minimal Change Nephrotic Syndrome in Pediatric Patients
Cyclophosphamide capsules are indicated for the treatment of biopsy proven minimal change nephrotic syndrome in pediatric patients who failed to adequately respond to or are unable to tolerate adrenocorticosteroid therapy.
Limitations of Use:
The safety and effectiveness of cyclophosphamide capsules for the treatment of nephrotic syndrome in adults or other renal disease has not been established.
From the FDA-approved label on DailyMed (published Sep 29, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02241795.
- It names Procytox, Cyclophosphamide 25 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Procytox by Baxter Corporation.
In Canada: prescription only.
Ingredients
Active: Cyclophosphamide
Other Cyclophosphamide pills
- 54 639 Cyclophosphamide 25 mg Blue, round, 9 mm Used for multiple sclerosis and myasthenia gravis
- 54 006 Cyclophosphamide 25 mg Blue, capsule, 8 mm Used for multiple sclerosis and myasthenia gravis
- A 346 Cyclophosphamide 25 mg Blue, capsule, 16 mm Used for multiple sclerosis and myasthenia gravis
- Cipla 51625MG Cyclophosphamide 25 mg White, capsule, 16 mm Used for multiple sclerosis and myasthenia gravis
- BXT 25 Cyclophosphamide 25 mg White, round, 9 mm Used for multiple sclerosis and myasthenia gravis
- NSP25 Cyclophosphamide 25 mg Blue, capsule, 16 mm Used for multiple sclerosis and myasthenia gravis
- 54 980 Cyclophosphamide 50 mg Blue, round, 11 mm Used for multiple sclerosis and myasthenia gravis
- 54 881 Cyclophosphamide 50 mg Blue, capsule, 10 mm Used for multiple sclerosis and myasthenia gravis